Achieving a New Controllable Male Contraception by the Photothermal Effect of Gold Nanorods
Source abstract
Abstract
During the process of human civilization, owning household pets has become increasingly popular. However, dogs and cats may be reservoirs or vectors of transmissible diseases to humans. Confronted with the overpopulation of pets, traditional contraception methods, surgical methods of sterilization, for animals are used, namely, ovariohysterectomy and orchidectomy. Therefore, a simple, nonsurgical, controllable, more effective and less expensive contraception method is highly desirable. In this study, we show that in situ testicular injection of methoxy poly(ethylene glycol)-modified gold nanorods with near-infrared irradiation in male mice can achieve short-lived or permanent male infertility. In a lower hyperthermia treatment, the morphology of testes and seminiferous tubules is only partly injured, and fertility indices are decreased to 10% at day 7, then recovered to 50% at day 60. In a higher hyperthermia treatment, the morphology of testes and seminiferous tubules are totally destroyed, and fertility indices are decreased to 0 at day 7. Overall, our results indicate a potential application of plasmonic nanomaterials for male contraception.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Sperm and Testicular Function · Gold and Silver Nanoparticles Synthesis and Applications · Nanocluster Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Cell and Developmental Biology, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China
Hefei National Laboratory for Physical Sciences at the Microscale, Hefei, Anhui 230027, China
References (26)
Show source-provided references
1. Olson P. N. · J. Reprod. Fertil. Suppl. · 1993 · 47 · 433
2. Kutzler M. · Theriogenology · 2006 · 66 · 51410.1016/j.theriogenology.2006.04.014 ↗
3. Howe L. M. · Theriogenology · 2006 · 66 · 50010.1016/j.theriogenology.2006.04.005 ↗
4. Paul C. · Reproduction · 2008 · 136 · 7310.1530/REP-08-0036 ↗
5. Choi W. I. · ACS Nano · 2011 · 5 · 199510.1021/nn103047r ↗
6. Kuo W. S. · Angew. Chem., Int. Ed. · 2010 · 49 · 271110.1002/anie.200906927 ↗
7. Huang X. H. · J. Am. Chem. Soc. · 2006 · 128 · 211510.1021/ja057254a ↗
8. Veronese F. M. · Drug Discovery Today · 2005 · 10 · 145110.1016/S1359-6446(05)03575-0 ↗
9. Goodrich G. P. · J. Biomed. Opt. · 2010 · 15 · 01800110.1117/1.3290817 ↗
10. Jana N. R. · J. Phys. Chem. B · 2001 · 105 · 406510.1021/jp0107964 ↗
11. Dickerson E. B. · Cancer Lett. · 2008 · 269 · 5710.1016/j.canlet.2008.04.026 ↗
12. Weissleder R. · Nat. Biotechnol. · 2001 · 19 · 31610.1038/86684 ↗
13. Fahim M. S. · Contraception · 1975 · 11 · 54910.1016/0010-7824(75)90109-2 ↗
14. Mollova M. · J. Reprod. Immunol. · 2011 · 90 · 17410.1016/j.jri.2011.06.080 ↗
15. Shilkina L. A. B. · Exp. Biol. Med. · 1976 · 82 · 186010.1007/BF00785720 ↗
16. Paul C. · Reproduction · 2008 · 136 · 7310.1530/REP-08-0036 ↗
17. Banks S. · Reproduction · 2005 · 129 · 50510.1530/rep.1.00531 ↗
18. Setchell B. P. · J. Reprod. Fertil. · 1998 · 114 · 17910.1530/jrf.0.1140179 ↗
19. Anderson R. A. · Endocr. Rev. · 2002 · 23 · 73510.1210/er.2002-0002 ↗
20. Bai Y. · Nat. Nanotechnol. · 2010 · 5 · 68310.1038/nnano.2010.153 ↗
21. Wang C. · J. Clin. Endocrinol. Metab. · 2007 · 92 · 329210.1210/jc.2007-0367 ↗
22. Sinha Hikim A. P. · J. Steroid Biochem. Mol. Biol. · 2003 · 85 · 17510.1016/S0960-0760(03)00193-6 ↗
23. He X. · Ann. Biomed. Eng. · 2004 · 32 · 138410.1114/B:ABME.0000042226.97347.de ↗
24. Lepock J. R. · Int. J. Hyperther. · 2003 · 19 · 25210.1080/0265673031000065042 ↗
25. Ullrich O. · FASEB J. · 2001 · 15 · 146010.1096/fj.00-0540fje ↗
26. Von Maltzahn G. · Cancer Res. · 2009 · 69 · 389210.1158/0008-5472.CAN-08-4242 ↗